BILL ANALYSIS                                                                                                                                                                                                    



                                                                  SB 364
                                                                  Page  1


          SENATE THIRD READING
          SB 364 (Florez)
          As Amended August 31, 2009
          Majority vote 

           SENATE VOTE  :21-15  
           
           HEALTH              10-7        APPROPRIATIONS      9-7         
           
           ----------------------------------------------------------------- 
          |Ayes:|Ammiano, Carter, De La    |Ayes:|De Leon, Ammiano, Coto,   |
          |     |Torre,                    |     |Davis, Fuentes, Skinner,  |
          |     |De Leon, Hayashi,         |     |Solorio, Torlakson, Hill  |
          |     |Hernandez,                |     |                          |
          |     |Bonnie Lowenthal, Nava,   |     |                          |
          |     |V. Manuel Perez, Salas    |     |                          |
          |     |                          |     |                          |
          |-----+--------------------------+-----+--------------------------|
          |Nays:|Jones, Fletcher, Adams,   |Nays:|Conway, Charles Calderon, |
          |     |Conway,                   |     |Harkey, Miller, Nielsen,  |
          |     |Emmerson, Gaines, Audra   |     |John A. Perez,            |
          |     |Strickland                |     |Audra Strickland          |
          |     |                          |     |                          |
           ----------------------------------------------------------------- 
           SUMMARY  :  Prohibits an officer, director, or member of a  
          governing board of a general acute care (GAC) hospital  
          designated by the National Cancer Institute (NCI) as a  
          comprehensive cancer center, and that accepts state funds, from  
          holding a position as an officer, director, or member of the  
          board, or a similar position, of a specified corporation.   
          Specifically,  this bill  :

          1)Prohibits an officer, director, or member of a governing board  
            of a GAC hospital that is designated by NCI as a comprehensive  
            cancer center to conduct cancer research and treatment, and  
            that accepts state funds, from holding a position as either of  
            the following:

             a)   An officer, director, or member of the board, or a  
               similar position, of a "corporation that manufactures or  
               sells tobacco products," defined as a corporation or other  
               entity that owns or operates licensed clinics, health  
               facilities, or pharmacies that derive revenue from tobacco,  
               or any entity that derives more than 1% of its annual  








                                                                  SB 364
                                                                  Page  2


               revenue from tobacco products; and,

             b)   An officer, director, or member of the board, or a  
               similar position, of a corporation that has, within the  
               past five years, violated federal or state controlled  
               substances laws or regulations.

          2)Makes legislative declarations that it is misleading for a GAC  
            hospital that is designated as a comprehensive cancer center,  
            and that is provided resources by the state, to employ  
            officers and directors who profit from the sale and  
            distribution of tobacco products.  Finds that such a hospital  
            should seek to ensure that its directors and officers do not  
            profit from the consumption of tobacco products and do not  
            render services to corporations that have violated federal or  
            state laws.

           EXISTING LAW  :

          1)Provides for the licensing and regulation of health care  
            facilities, including GAC hospitals, acute psychiatric  
            hospitals, and special hospitals by the Department of Public  
            Health (DPH).

          2)Provides that an application for licensure as a health care  
            facility may be denied by DPH if the applicant, or a  
            significant officer, director, or shareholder, of an applicant  
            firm, partnership, corporation or public entity, has been  
            convicted of a crime, as defined, or knowingly makes a false  
            statement of fact in an application for such licensure.

          3)Requires DPH to consider several factors concerning an  
            applicant seeking licensure of a health care facility,  
            including whether the applicant is of reputable and  
            responsible character and has the ability to comply with state  
            and federal licensing laws and regulations, as specified.

           FISCAL EFFECT  :  According to the Assembly Appropriations  
          Committee, no direct fiscal impact resulting from the  
          prohibitions established by the bill.

           COMMENTS  :  According to the author, this bill is intended to  
          prevent cancer research and treatment facilities that receive  
          state funds from employing or appointing officers and directors  








                                                                 SB 364
                                                                  Page  3


          who also hold positions in corporations that either profit from  
          the sale and distribution of tobacco products, or have violated  
          federal or state controlled substances laws and regulations.   
          The prohibitions in the bill are designed to prevent potential  
          conflicts of interest for governing board members of  
          California's 10 NCI-designated comprehensive cancer centers.

          The California Medical Association (CMA) supports this bill.   
          CMA states that, due to the serious inherent health risks from  
          smoking, CMA physicians strongly discourage smoking and support  
          ways to restrict minors' access to tobacco products to prevent  
          their becoming addicted and that the organization has long  
          called for hospitals, pharmacies, and other establishments where  
          health care services are delivered to refrain from selling or  
          allowing the consumption of tobacco products on its premises.   
          CMA argues that the relationships pondered by this bill are not  
          only unacceptable conflicts of interest but also are of dubious  
          benefit to patients and may in fact cause harm.  CMA maintains  
          that no health entity should be affiliated with any person or  
          entity that profits from tobacco addiction and certainly not  
          cancer research hospitals.

          The California Chamber of Commerce, the California Grocers  
          Association, and the California Retailers Association are  
          opposed to this bill.  The opposition argues that the sale of  
          tobacco products is legal in California and that prohibiting  
          individuals associated with tobacco from serving their  
          communities is an over-reaching government intrusion.  The  
          opposition also argues that this bill presents a slippery slope  
          to other legal products and forcing the removal and barring the  
          appointment of these individuals from service on boards does not  
          benefit the community.

          Recent amendments remove the opposition of BayBio, the  
          California Healthcare Institute, and the Pharmaceutical Research  
          and Manufacturers of America by striking provisions that  
          additionally would have prohibited service on the board of a  
          biopharmaceutical company involved with therapeutic products for  
          diseases such as diabetes and cancer.  

           
           Analysis Prepared by  :    Joyce Iseri / HEALTH (916) 319 2097










                                                                  SB 364
                                                                  Page  4


                                                                FN: 0002664